Multiple studies have recently reported that HDAC1 has become a promising anticancer target since HDAC inhibitors can induce tumor cell apoptosis and inhibit angiogenesis.[41] Therefore, inhibition of HDAC signaling may result in broad disturbances in normal cellular functions. Here, HDAC9 is linked to neoplasm.